1. Wang, Siying, Zhou, Yangyang, Yu, Ruobing, Qin, Wenxin, Jin, Haojie. 2023. Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2. In JHEP reports : innovation in hepatology, 5, 100843. doi:10.1016/j.jhepr.2023.100843. https://pubmed.ncbi.nlm.nih.gov/37675273/
2. Chen, Jiajia, Yang, Yang, Lin, Bingquan, Huang, Zehai, Huang, Wenhua. 2021. Hollow mesoporous organosilica nanotheranostics incorporating formimidoyltransferase cyclodeaminase (FTCD) plasmids for magnetic resonance imaging and tetrahydrofolate metabolism fission on hepatocellular carcinoma. In International journal of pharmaceutics, 612, 121281. doi:10.1016/j.ijpharm.2021.121281. https://pubmed.ncbi.nlm.nih.gov/34774692/
3. Greenwood, Pamela M, Schmidt, Kevin, Lin, Ming-Kuan, Parasuraman, Raja, Jankord, Ryan. 2018. A functional promoter variant of the human formimidoyltransferase cyclodeaminase (FTCD) gene is associated with working memory performance in young but not older adults. In Neuropsychology, 32, 973-984. doi:10.1037/neu0000470. https://pubmed.ncbi.nlm.nih.gov/29927301/
4. Chen, Erbao, Zou, Zhilin, Wang, Rongyue, Lin, Zewei, Liu, Jikui. 2024. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies. In Frontiers in immunology, 15, 1244392. doi:10.3389/fimmu.2024.1244392. https://pubmed.ncbi.nlm.nih.gov/38694506/
智鼠故事 
